HBSC News HBS BioEnergy Appoints Mr. Claude Luster as President for its Renewable Energy Business
PALO ALTO, Calif.--(BUSINESS WIRE)--Human BioSystems (OTCBB:HBSC) (“HBS”)
announced today that HBS BioEnergy (“HBS Bio”),
a wholly owned subsidiary of HBS, has appointed Mr. Claude Luster III as
HBS BioEnergy’s President, pursuant to the
agreement signed between HBS and HBS Bio in September, 2006. Mr. Luster,
the founder of EXL III Group Corporation (EXL III), has been involved in
the final stages of developing and funding a 60-million gallon Northern
California ethanol facility which he will complete while assuming his
new duties with HBS BioEnergy.
“Among Mr. Luster’s
first duties will be to develop necessary strategic partners and
consulting firms that HBS BioEnergy will need for the initial stages of
production,” stated Harry Masuda, CEO of Human
BioSystems. “We are pleased to have Claude as
our President. He has the technical and management background and the
essential skills that HBS has been seeking,”
Mr. Masuda continued.
Mr. Luster was instrumental with EXL III’s
current plans to develop up to 10 renewable fuels plants and 10 value
added bioconversion facilities. EXL III is also developing several new
cost reduction processes for the production of ethanol and biodiesel.
Prior to his involvement with the EXL III, Mr. Luster was President and
CEO of EXL Group, a Portfolio Investment Company of Impact Capital
Partners of Oakland, CA which includes Wells Fargo and, Washington
Mutual as Limited Partners.
Mr. Luster has more than 30 years experience in the food-processing,
bio-conversion, energy and environmental industries and is considered
one of the food industry’s leading experts in
the field of aseptic processing and aseptic bulk plant operations. These
involve highly complex processes utilizing sophisticated equipment and
manufacturing procedures. Ethanol production utilizes processes and
equipment that bear close resemblance to those of the food processing
industry.
Included amongst Mr. Luster’s credentials are
the conception, development and implementation of novel aseptic
processes and protocols directed towards developing Greenfield food
processing and bio-conversion facilities in the United States, Canada,
China and Africa. He owned and operated LusTek Labs and Consulting as
well as serving as consultant in the food processing, bio-conversion,
energy and environmental industries. He was a major shareholder in Helm
Concentrates, Inc., which was subsequently sold to ConAgra Foods, Inc.
Mr. Luster has held numerous technical, scientific and management
positions including Process Technician for General Foods, Inc., Process
Operations and Research Manager for Tri-Valley Growers, Fermentation
Manager for Miller Brewing Company, Vice President of Operations for
Helm Concentrates, Inc. and Technical Leader for Hunt-Wesson Foods, Inc.
While at Helm Concentrates Inc, Mr. Luster designed and supervised the
construction of one of the most sophisticated aseptic processing plants
in California.
“I see HBS Bio as an innovative company,
prepared to join the burgeoning group of professionals who keep abreast
of the ever-shifting trends in energy and environmental markets and who
are constantly working to provide optimal solutions for the consumer. I’m
pleased to be appointed to the position of President and look forward to
a strong future with HBS Bio,” stated Claude
Luster III, President of HBS BioEnergy.
In September of 2006, HBS created HBS BioEnergy, a wholly owned
subsidiary dedicated to the development facilities that produce ethanol
and other biofuels.
Human BioSystems is a developer of preservation platforms for organs and
other bio-materials. HBS is headquartered in Palo Alto, California with
research facilities in Michigan and has been granted four patents by the
U.S. Patent Office.
Certain statements contained herein are “forward-looking''
statements (as such term is defined in the Private Securities Litigation
Reform Act of 1995). Because such statements include risks and
uncertainties, actual results may differ materially from those expressed
or implied by such forward-looking statements. Factors that could cause
results to differ materially from those expressed or implied by such
forward-looking statements include, but are not limited to, failure to
obtain regulatory approvals for the construction of ethanol plants,
failure to obtain the required financing and to construct the ethanol
plants, failure of the ethanol plants to meet standards, the inability
to find raw material for the production of ethanol or to sell the
ethanol at acceptable terms, the risks involved in pursuing a business
unrelated to HBS’ prior business, and other
factors discussed in filings made by the Company with the Securities and
Exchange Commission
